Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 5:06 pm Purchase | 2026-03-31 | 13G | BICARA THERAPEUTICS INC BCAX | Vestal Point Capital, LP | 5,425,000 8.300% | 1,850,000 (+51.75%) | Filing History |
| 2026-05-15 11:43 am Purchase | 2026-03-31 | 13G | BICARA THERAPEUTICS INC BCAX | JANUS HENDERSON GROUP PLC JHG | 3,339,218 5.100% | 3,339,218 (New Position) | Filing History |
| 2026-05-15 08:38 am Purchase | 2026-03-31 | 13G | BICARA THERAPEUTICS INC BCAX | Deep Track Capital, LP | 4,062,500 6.210% | 1,312,500 (+47.73%) | Filing History |
| 2026-05-08 9:22 pm Unchanged | 2026-03-31 | 13G | BICARA THERAPEUTICS INC BCAX | Red Tree GP, LLC | 3,170,509 4.800% | 0 (Unchanged) | Filing History |
| 2026-05-06 11:00 am Sale | 2026-03-31 | 13G | BICARA THERAPEUTICS INC BCAX | FMR LLC | 2,100,929 3.200% | -1,246,294 (-37.23%) | Filing History |
| 2026-04-08 3:26 pm Purchase | 2026-03-31 | 13G | BICARA THERAPEUTICS INC BCAX | T. Rowe Price Investment Management, Inc. | 6,605,780 10.100% | 3,369,185 (+104.10%) | Filing History |
| 2026-03-02 4:25 pm Purchase | 2026-02-26 | 13D | BICARA THERAPEUTICS INC BCAX | RA Capital Management, L.P. | 7,279,739 11.500% | 323,746 (+4.65%) | Filing History |
| 2026-02-17 4:10 pm Sale | 2025-12-31 | 13G | BICARA THERAPEUTICS INC BCAX | Vestal Point Capital, LP | 3,575,000 6.500% | -1,425,000 (-28.50%) | Filing History |
| 2026-02-17 10:28 am Purchase | 2025-12-31 | 13G | BICARA THERAPEUTICS INC BCAX | T. Rowe Price Investment Management, Inc. | 3,236,595 5.900% | 3,236,595 (New Position) | Filing History |
| 2026-02-12 4:19 pm Purchase | 2026-02-05 | 13G | BICARA THERAPEUTICS INC BCAX | Deep Track Capital, LP | 2,750,000 5.020% | 2,750,000 (New Position) | Filing History |
| 2026-02-05 1:16 pm Purchase | 2025-12-31 | 13G | BICARA THERAPEUTICS INC BCAX | FMR LLC | 3,347,223 6.100% | 591,006 (+21.44%) | Filing History |
| 2025-08-14 3:57 pm Purchase | 2025-06-30 | 13G | BICARA THERAPEUTICS INC BCAX | Vestal Point Capital, LP | 5,000,000 9.200% | 2,231,025 (+80.57%) | Filing History |
| 2025-07-31 2:56 pm Purchase | 2025-06-30 | 13G | BICARA THERAPEUTICS INC BCAX | Invus Global Management, LLC | 5,216,969 9.600% | 2,144,142 (+69.78%) | Filing History |
| 2025-07-17 11:11 am Purchase | 2025-07-10 | 13G | BICARA THERAPEUTICS INC BCAX | FMR LLC | 2,756,217 5.100% | 217,813 (+8.58%) | Filing History |
| 2025-07-17 11:08 am Sale | 2025-06-30 | 13G | BICARA THERAPEUTICS INC BCAX | FMR LLC | 2,538,404 4.700% | -1,073,169 (-29.71%) | Filing History |
| 2025-05-15 4:13 pm Purchase | 2025-03-31 | 13G | BICARA THERAPEUTICS INC BCAX | Vestal Point Capital, LP | 2,768,975 5.100% | 2,768,975 (New Position) | Filing History |
| 2025-05-12 10:28 am Purchase | 2025-03-31 | 13G | BICARA THERAPEUTICS INC BCAX | FMR LLC | 3,611,573 6.600% | 807,766 (+28.81%) | Filing History |
| 2025-03-03 09:14 am Purchase | 2025-02-24 | 13G | BICARA THERAPEUTICS INC BCAX | FMR LLC | 2,803,807 5.200% | 686,719 (+32.44%) | Filing History |
| 2025-02-12 09:16 am Sale | 2024-12-31 | 13G | BICARA THERAPEUTICS INC BCAX | FMR LLC | 2,117,088 3.900% | -378,245 (-15.16%) | Filing History |
| 2024-09-26 4:30 pm Purchase | 2024-09-16 | 13G | BICARA THERAPEUTICS INC BCAX | Invus Global Management, LLC | 3,072,827 5.700% | 3,072,827 (New Position) | Filing History |